Catriona Jamieson
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments 62
- Acute Myeloid Leukemia Research 28
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 40
- Chronic Lymphocytic Leukemia Research 34
- Oncology top 0.5%
- Cancer Research top 0.5%
- Molecular Biology top 0.5%
- RNA Research and Splicing 26
- RNA regulation and disease 23
- Hedgehog Signaling Pathway Studies 17
-
- Acute Lymphoblastic Leukemia research 13
- Co-authors
- Irving L. WeissmanGeoffrey M. WahlPeter B. DirksD. Leanne JonesJohn E. DickJane E. VisvaderConnie J. EavesMichael F. Clarke
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Catriona Jamieson
177 papers receiving 12.0k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Hematology 3.4k
- Genetics 2.9k
- Oncology 4.1k
- Cancer Research 1.8k
- Molecular Biology 6.7k
Countries citing papers authored by Catriona Jamieson
This map shows the geographic impact of Catriona Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catriona Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catriona Jamieson more than expected).
Fields of papers citing papers by Catriona Jamieson
This network shows the impact of papers produced by Catriona Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catriona Jamieson. The network helps show where Catriona Jamieson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Catriona Jamieson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 40 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 38 | |
| 11 | 2019 | 52 | |
| 12 | 2019 | 12 | |
| 13 | 2017 | 1 | |
| 14 | 2015 | 31 | |
| 15 | 2011 | 310 | |
| 16 | 2010 | 1 | |
| 17 | 2010 | 43 | |
| 18 | 2009 | 2 | |
| 19 | Cancer stem cell targeted therapy: Removing the sword of Damocles | 2007 | 1 |
| 20 | 1993 | 11 |
About Catriona Jamieson
Catriona Jamieson is a scholar working on Hematology, Genetics and Oncology, having authored 187 papers that have together received 12.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (62 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (34 papers), Acute Myeloid Leukemia Research (28 papers), RNA Research and Splicing (26 papers), RNA regulation and disease (23 papers), Hedgehog Signaling Pathway Studies (17 papers) and Acute Lymphoblastic Leukemia research (13 papers). The work is most often cited by research in Hematology (3.4k citations), Genetics (2.9k citations) and Oncology (4.1k citations). Catriona Jamieson has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Irving L. Weissman, Geoffrey M. Wahl, Peter B. Dirks, D. Leanne Jones, John E. Dick, Jane E. Visvader, Connie J. Eaves, Michael F. Clarke, Derrick J. Rossi and Laurie Ailles. Their work appears in journals such as Nature, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.